Vivek Garipalli is Director & 10% Owner at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). They have made 3 open-market trades across 1 company since 2024, most recently 2026-01-07.
CIK 0001839260
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $5.0M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLOV | 3,512,196 | $15.8M |
Shares reported on the most recent Form 4, priced at the 2026-01-09 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.